FIM
JAZZ icon

Freedom Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Freedom Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,468
Closed -$262K – 417
2025
Q2 		$262K Buy
2,468
+348
+16% +$37.8K 0.02% 632
2025
Q1 		$263K Sell
2,120
-286
-12% -$37.3K 0.02% 633
2024
Q4 		$296K Buy
2,406
+276
+13% +$32.5K 0.02% 602
2024
Q3 		$237K Sell
2,130
-104
-5% -$11.4K 0.02% 667
2024
Q2 		$238K Buy
2,234
+336
+18% +$36.9K 0.02% 673
2024
Q1 		$229K Sell
1,898
-612
-24% -$75K 0.02% 698
2023
Q4 		$309K Sell
2,510
-126
-5% -$15.7K 0.03% 585
2023
Q3 		$341K Sell
2,636
-1,035
-28% -$138K 0.04% 459
2023
Q2 		$455K Buy
3,671
+619
+20% +$83.3K 0.05% 423
2023
Q1 		$447K Sell
3,052
-186
-6% -$27.5K 0.05% 431
2022
Q4 		$516K Sell
3,238
-1,105
-25% -$162K 0.06% 413
2022
Q3 		$579K Buy
4,343
+843
+24% +$128K 0.07% 371
2022
Q2 		$546K Sell
3,500
-96
-3% -$14.8K 0.06% 424
2022
Q1 		$560K Sell
3,596
-259
-7% -$37.6K 0.05% 439
2021
Q4 		$491K Sell
3,855
-101
-3% -$13.3K 0.04% 523
2021
Q3 		$515K Sell
3,956
-172
-4% -$26K 0.04% 498
2021
Q2 		$733K Sell
4,128
-1,510
-27% -$262K 0.05% 417
2021
Q1 		$927K Sell
5,638
-972
-15% -$160K 0.07% 324
2020
Q4 		$1.09M Sell
6,610
-1,005
-13% -$150K 0.12% 172
2020
Q3 		$1.09M Sell
7,615
-437
-5% -$54.2K 0.12% 165
2020
Q2 		$888K Sell
8,052
-1,884
-19% -$208K 0.1% 180
2020
Q1 		$1.42M Buy
9,936
+293
+3% +$37.9K 0.13% 154
2019
Q4 		$1.44M Sell
9,643
-1,065
-10% -$145K 0.13% 160
2019
Q3 		$1.37M Sell
10,708
-1,769
-14% -$237K 0.12% 168
2019
Q2 		$1.78M Sell
12,477
-742
-6% -$99.7K 0.15% 145
2019
Q1 		$1.89M Sell
13,219
-240
-2% -$31.3K 0.15% 150
2018
Q4 		$1.67M Sell
13,459
-1,003
-7% -$149K 0.13% 156
2018
Q3 		$2.48M Sell
14,462
-599
-4% -$103K 0.16% 118
2018
Q2 		$2.6M Buy
15,061
+6,636
+79% +$1.08M 0.16% 111
2018
Q1 		$1.27M Buy
8,425
+136
+2% +$19.9K 0.06% 296
2017
Q4 		$1.12M Buy
8,289
+251
+3% +$34.8K 0.06% 325
2017
Q3 		$1.18M Sell
8,038
-3,937
-33% -$595K 0.06% 281
2017
Q2 		$1.86M Buy
11,975
+775
+7% +$119K 0.11% 137
2017
Q1 		$1.63M Buy
11,200
+140
+1% +$18.2K 0.09% 161
2016
Q4 		$1.21M Sell
11,060
-1,802
-14% -$201K 0.08% 199
2016
Q3 		$1.56M Sell
12,862
-414
-3% -$55.8K 0.1% 138
2016
Q2 		$1.88M Buy
13,276
+535
+4% +$78.9K 0.13% 93
2016
Q1 		$1.66M Buy
12,741
+990
+8% +$123K 0.12% 108
2015
Q4 		$1.65M Sell
11,751
-9,850
-46% -$1.36M 0.13% 109
2015
Q3 		$398K Buy
21,601
+13,485
+166% +$2.32M 0.04% 385
2015
Q2 		$1.43M Buy
8,116
+2,523
+45% +$453K 0.15% 98
2015
Q1 		$966K Buy
5,593
+2,658
+91% +$456K 0.11% 144
2014
Q4 		$481K Buy
2,935
+1,287
+78% +$214K 0.06% 297
2014
Q3 		$265K Buy
+1,648
New +$253K 0.05% 369

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Freedom Investment Management's JAZZ Position: Q3 2025 in Review

Freedom Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2025, closing a stake of 2,468 shares — an estimated $262K sold.

Freedom Investment Management first reported a position in JAZZ in Q3 2014 and held it in 44 quarters. The position peaked at $2.6M in Q2 2018. 502 funds tracked by Wall St. Rank hold JAZZ as of Q3 2025.

  • Freedom Investment Management reported no remaining Jazz Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Freedom Investment Management sold 2,468 Jazz Pharmaceuticals shares in Q3 2025, an estimated $262K.
  • Freedom Investment Management first reported a position in Jazz Pharmaceuticals in Q3 2014 and held it in 44 quarters.
  • Freedom Investment Management's Jazz Pharmaceuticals position peaked at $2.6M in Q2 2018.
  • 502 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2025.

Based on Freedom Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.